U.S. Dietary Supplements Industry Overview

The U.S. dietary supplement market size was estimated at USD 53.58 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030. 

The primary factors driving the market growth are the growing population of senior citizens, rising awareness and focus on preventive healthcare, and rising demand for sports nutrition supplements. Additionally, consumers are moving towards self-directed care, which is also expected to drive demand for dietary supplements in the U.S.

Gather more insights about the market drivers, restrains and growth of the U.S. Dietary Supplements Market

Consumers in the U.S. are shifting towards self-directed care, which has helped in shaping the growth of the dietary supplements industry in the country. Consumers are opting for nutraceuticals rather than prescription pharmaceuticals owing to the growing focus on preventive healthcare. The high cost of prescription pharmaceuticals and the reluctance of insurance companies to cover the cost of drugs have further helped the dietary supplements industry solidify its presence in the U.S. market. Increasing hospitalization costs are driving consumers toward nutraceutical and health supplements, further aiding the market growth.

Factors fueling interest in dietary supplements in the U.S. include growing healthcare costs, changes in food laws affecting label and product claims, rapid advances in science and technology, rising geriatric population, and growing interest in attaining wellness through diet.

Browse through Grand View Research's Nutraceuticals & Functional Foods Industry Research Reports.

• The global dietary supplements market size was valued at USD 177.50 billion in 2023 and is projected to grow at a CAGR of 9.1% from 2024 to 2030. 
• The global prebiotics market size was valued at USD 6.05 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 14.9% from 2022 to 2030.

U.S. Dietary Supplements Market Segmentation

U.S. Dietary Supplements Application-End User Outlook (Revenue, USD Million, 2018 - 2030)

• Energy & Weight Management
  1. Adults
     1. Male
     2. Female
  2. Geriatric
  3. Pregnant Women
  4. Children
  5. Infants
• General Health
  1. Adults
     1. Male
     2. Female
  2. Geriatric
  3. Pregnant Women
  4. Children
  5. Infants
• Bone & Joint Health
  1. Adults
     1. Male
     2. Female
  2. Geriatric
  3. Pregnant Women
  4. Children
  5. Infants
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Anti-cancer
• Diabetes
• Lungs Detox/Cleanse
• Skin/Hair/Nails
• Sexual Health
• Brain/Mental Health
• Insomnia
• Menopause
• Anti-aging
• Prenatal Health
• Others

U.S. Dietary Supplements Application-Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

• Energy & Weight Management
  1. Vitamins
  2. Botanicals
  3. Minerals
  4. Proteins & Amino acids
     1. Collagen
     2. Others
  5. Fibers & Specialty Carbohydrates
  6. Omega Fatty Acids
  7. Probiotics
  8. Others
• General Health
  1. Vitamins
  2. Botanicals
  3. Minerals
  4. Proteins & Amino acids
     1. Collagen
     2. Others
  5. Fibers & Specialty Carbohydrates
  6. Omega Fatty Acids
  7. Probiotics
  8. Others
• Bone & Joint Health
  1. Vitamins
  2. Botanicals
  3. Minerals
  4. Proteins & Amino acids
     1. Collagen
     2. Others
  5. Fibers & Specialty Carbohydrates
  6. Omega Fatty Acids
  7. Probiotics
  8. Others
• Gastrointestinal Health
  1. Vitamins
  2. Botanicals
  3. Minerals
  4. Proteins & Amino acids
     1. Collagen
     2. Others
  5. Fibers & Specialty Carbohydrates
  6. Omega Fatty Acids
  7. Probiotics
  8. Others
• Immunity
• Cardiac Health
• Anti-cancer
• Diabetes
• Lungs Detox/Cleanse
• Skin/Hair/Nails
• Sexual Health
• Brain/Mental Health
• Insomnia
• Menopause
• Anti-aging
• Prenatal Health
• Others

U.S. Dietary Supplements Form Outlook (Revenue, USD Million, 2018 - 2030)

• Tablets
• Capsules
• Soft Gels
• Powders
• Gummies
• Liquids
• Others

U.S. Dietary Supplements Type Outlook (Revenue, USD Million, 2018 - 2030)

• OTC
• Prescribed

U.S. Dietary Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Offline
• Online

Key Companies profiled:

• Amway
• Abbott
• Bayer AG
• Glanbia plc.
• Pfizer Inc.
• Archer Daniels Midland
• GlaxoSmithKline plc.
• NU SKIN
• Herbalife Nutrition
• Nature's Sunshine Products Inc.
• DuPont de Nemours Inc.
• NOW Foods

Key U.S. Dietary Supplements Company Insights

The market includes both international and domestic participants. Brand market share analysis indicates that key market players are focusing on strategies such as new product launches, partnerships, mergers & acquisitions, global expansion, and others. Some of the largest dietary supplement companies including Amway, Bayer AG, GlaxoSmithKline plc have entered into the market.

Recent Developments

• In May 2024, Bayer launched a One A Day social media campaign featuring former NFL star Julian Edelman to combat wellness misinformation. The campaign started running across major social platforms, including Instagram, Facebook, and TikTok. Its primary objective was to inspire individuals to share honest accounts of their wellness experiences, countering the often unrealistic or pseudoscientific claims in online wellness spaces.
• In May 2024, NOW Foods reaffirmed its commitment to independent retailers by launching 20 product sizes exclusively available for sale in brick-and-mortar stores. These specially tailored products, which include popular items like 5HTP, CoQ10, probiotics, and vitamin D, fill a niche between the typical small and large bottle quantities offered by NOW. Each product prominently features an "In store only" logo on its label.

Order a free sample PDF of the U.S. Dietary Supplements Market Intelligence Study, published by Grand View Research.